Yuhe Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuhe Zhao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bi Huang
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China
2 shared publications - Bryan Richard Sasmita
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications - Suxin Luo
Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, China
2 shared publications - Jing Chen
Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication - Linfeng Xie
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Ming Gong
Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University, 400016, Chongqing, China
1 shared publication
Latest Publications
- 1 January 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 447, 134142
Extracellular water to lean body mass ratio predicts mortality in patients with chronic heart failure: A prospective, observational study
- 1 January 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 447, 134142
Extracellular water to lean body mass ratio predicts mortality in patients with chronic heart failure: A prospective, observational study
- Open Access
- 18 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 5
Edema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study
Introduction: Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one’s congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF). Methods: A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality. Results: Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003). Conclusions: Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.
- 18 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 5
Open AccessEdema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study
Introduction: Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one’s congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF). Methods: A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality. Results: Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003). Conclusions: Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.